# Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant

> **NCT02526329** · PHASE1 · WITHDRAWN · sponsor: **Everett Meyer**

## Conditions studied

- Graft Versus Host Disease

## Interventions

- **BIOLOGICAL:** donor regulatory T lymphocytes
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT02526329
- **Lead sponsor:** Everett Meyer
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-08-06
- **Primary completion:** 2022-11
- **Final completion:** 2023-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Logistics
- **Last updated:** 2023-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02526329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02526329, "Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02526329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*